Nonalcoholic Steatohepatitis: Definition and Pathology
By E. Brunt. Seminars in liver disease (Print), 2001
1,008 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/4a93f7c469db264d42e3f49914a9b7e784f45ee5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Hepatology
- J. Clark
- A. McCullough
- R. Lopez
- S. Dasarathy
- A. Khiyami
- R. Joseph
- Jaividhya Dasarathy
- Shira Zelber-Sagi
In Pathology and Forensic Medicine
- J. Clark
- A. McCullough
- S. Dasarathy
- R. Lopez
- A. Khiyami
- R. Joseph
- Jaividhya Dasarathy
- Shira Zelber-Sagi
Citations in the corpus
- Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005, neutral): “using the criteria described by Brunt [22].”
- The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. (2006, methodology): “Patients with NASH disease are evaluated histologically by grading the extent of hepatocyte ballooning, steatosis, and lobular inflammation (Brunt, 2001; 2004); the modified Brunt criteria were used to grade the steatohepatitis in Pemt 2 / 2 mice.”
- The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults (2006, background): “NAFLD is characterized pathologically by macrovesicular steatosis, mild diffuse lobular mixed acute and chronic inflammation, perivenular and zone 3 perisinusoidal collagen deposition, hepatocyte ballooning, poorly formed Mallory’s hyaline, vacuolated nuclei in periportal hepatocytes, lobular lipogr”
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings (2011, background): “’’ It is, however, increasingly apparent from ongoing and published studies that the numeric value of the composite NAS is considered by some investigators to be either ‘‘synonymous’’ with, or actually a replacement for, a microscopic diagnosis that is based on overall pattern of injury as well as t”
- The prevalence and etiology of elevated aminotransferase levels in the United States (2003, background): “, bridging fibrosis and cirrhosis) may accompany seemingly mild aminotransferase elevations (3, 6, 7).”
- Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. (2009, methodology): “For patients with nonalcoholic fatty liver disease, the extent of liver steatosis and the degree of fibrosis and necroinflammatory activity were assessed histologically according to the Brunt [23, 24] criteria.”
- Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study (2009, methodology): “The diagnosis of NASH and steatosis were made using previously described criteria [21].”
- The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. (2003, neutral): “NASH is a clinicopathological syndrome that is closely associated with obesity, insulin resistance, and type 2 diabetes (14).”
- Histopathology of pediatric nonalcoholic fatty liver disease (2005, neutral): “5) 1 (6) 9 (53) 2 (4) Other 1 (1) 0 (0) 0 (0) 0 (0) 1 (2) BMI (kg/m2) Mean (SD) 31.”